Hot Features
Premium
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Zeitraum:
Zeichenmodus:
| Volumen | 640.390 |
|
|||||
| News | - | ||||||
| Tageshoch | 6,16 | Niedrig Hoch |
|||||
| Tagestief | 5,925 | ||||||
| Name | Symbol | Markt | Aktientyp |
|---|---|---|---|
| Vanda Pharmaceuticals Inc | VNDA | NASDAQ | Common Stock |
| Änderung | Änderung % | Aktuell | Zeit
|
|
|---|---|---|---|---|
| -0,14 | -2,29% | 5,98 | 23:08:10 |
| Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
|---|---|---|---|---|
| 6,12 | 5,925 | 6,16 | 5,98 | 6,12 |
| Trades | Volumen | VWAP | Finanzielles Volumen | Durchsch. Volumen | 52 Week Range |
|---|---|---|---|---|---|
| 6.852 | 640.390 | US$ 6,03 | US$ 3.859.798 | - | 3,295 - 6,76 |
| Letzte Trade | Typ | Menge | Kurs | Währung |
|---|---|---|---|---|
| 01:37:24 | 42 | US$ 5,99 | USD |
Option-Flow Vanda Pharmaceuticals (VNDA)
Finanzwerte VNDA
| Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
|---|---|---|---|---|---|---|
| 348,03M | 58,20M | - | 192,64M | 2,51M | 0,04 | 138,75 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Vanda Pharmaceuticals
| Datum | Zeit | Quelle | Überschrift |
|---|---|---|---|
| 20.6.2024 | 02:48 | PR Newswire (US) | Vanda Pharmaceuticals Board of Directors Determines that.. |
| 13.6.2024 | 22:38 | Edgar (US Regulatory) | Form 8-K - Current report |
| 13.6.2024 | 16:02 | PR Newswire (US) | Vanda Pharmaceuticals Confirms Receipt of Revised.. |
| 06.6.2024 | 22:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 06.6.2024 | 15:24 | PR Newswire (US) | Vanda Pharmaceuticals Confirms Receipt of Unsolicited,.. |
| 30.5.2024 | 23:20 | PR Newswire (US) | Vanda Pharmaceuticals Announces Participation in the.. |
| 30.5.2024 | 22:48 | PR Newswire (US) | Vanda Pharmaceuticals Announces Completion of Transfer of.. |
| 29.5.2024 | 20:17 | PR Newswire (US) | Vanda Pharmaceuticals Announces Presentations at SLEEP 2024 |
| 24.5.2024 | 22:49 | Edgar (US Regulatory) | Form 8-K - Current report |
| 24.5.2024 | 22:46 | PR Newswire (US) | Vanda Pharmaceuticals Board of Directors Determines that.. |
| 24.5.2024 | 22:43 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 24.5.2024 | 22:31 | Edgar (US Regulatory) | Form 8-K/A - Current report: [Amend] |
Forum Vanda Pharmaceuticals
Keine Diskussionen Gefunden.Neuen Thread Erstellen
VNDA Historisch
| Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
|---|---|---|---|---|---|---|---|
| 1 Woche | 6,30 | 6,63 | 5,74 | 6,16 | 1.344.844 | -0,32 | -5,08% |
| 1 Monat | 5,22 | 6,75 | 4,86 | 6,04 | 1.662.583 | 0,76 | 14,56% |
| 3 Monate | 4,23 | 6,75 | 3,87 | 5,21 | 2.743.799 | 1,75 | 41,37% |
| 6 Monate | 4,02 | 6,75 | 3,46 | 4,87 | 1.810.623 | 1,96 | 48,76% |
| 1 Jahr | 6,56 | 6,76 | 3,295 | 4,79 | 1.406.599 | -0,58 | -8,84% |
| 3 Jahre | 18,93 | 21,8627 | 3,295 | 7,56 | 812.130 | -12,95 | -68,41% |
| 5 Jahre | 14,11 | 21,8627 | 3,295 | 9,44 | 713.896 | -8,13 | -57,62% |
